Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.

Antimicrobial Agents and Chemotherapy
N J LegakisH Kotsifaki

Abstract

Spontaneous mutants of Pseudomonas aeruginosa selected by ciprofloxacin were studied for outer membrane alterations. Acquisition of ciprofloxacin resistance was at least partially related to defects in lipopolysaccharide synthesis. When ciprofloxacin resistance was combined with resistance to beta-lactams and aminoglycosides, several alterations in outer membrane proteins were noted.

References

Jun 1, 1977·Canadian Journal of Microbiology·A M KropinskiF H Milazzo
Mar 1, 1985·Microbiological Reviews·H Nikaido, M Vaara
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·H AoyamaS Mitsuhashi
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·N J Robillard, A L Scarpa
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·J S Wolfson, D C Hooper
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·D C HooperM N Swartz
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·A J GodfreyL E Bryan
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·K HiraiS Mitsuhashi
May 1, 1987·Antimicrobial Agents and Chemotherapy·K H BüscherW Opferkuch
Jun 1, 1987·European Journal of Clinical Microbiology·N J LegakisJ Papavassiliou
Nov 1, 1987·Antimicrobial Agents and Chemotherapy·M Michéa-HamzehpourJ C Pechère
Apr 1, 1983·European Journal of Clinical Microbiology·A Bauernfeind, C Petermüller
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·N X Chin, H C Neu
Sep 1, 1982·Journal of Clinical Microbiology·N J LegakisM Papapetropoulou

❮ Previous
Next ❯

Citations

May 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H S Sader, R N Jones
Jan 1, 1991·International Journal of Antimicrobial Agents·P M Shah
Jan 1, 1993·International Journal of Antimicrobial Agents·A Bryskier
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·R A Celesk, N J Robillard
Oct 1, 1990·Antimicrobial Agents and Chemotherapy·N J Robillard
Feb 1, 1990·Antimicrobial Agents and Chemotherapy·B L MasecarN J Robillard
Sep 1, 1990·Antimicrobial Agents and Chemotherapy·H FukudaS Iyobe
Mar 1, 1991·Antimicrobial Agents and Chemotherapy·M Michea-HamzehpourJ C Pechere
May 1, 1992·Antimicrobial Agents and Chemotherapy·L J PiddockR E Hancock
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·C A DayD F Day
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·H FukudaK Hirai
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·E CharvalosJ C Pechere
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·K Poole
Jun 9, 2001·Intensive Care Medicine·J Rello, E Diaz
Jan 1, 1994·Infection·B Wiedemann, P Heisig
Nov 30, 1989·The American Journal of Medicine·N X ChinH C Neu
Feb 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Panayotis T. TassiosNicholas J. Legakis
Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T A GillespieM F Hanson
Mar 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F Van BambekeP M Tulkens
Apr 1, 1990·Journal of Chemotherapy·H KotsifakiN J Legakis
Oct 1, 1994·FEMS Microbiology Letters·N GotohT Nishino
Oct 1, 1991·Antimicrobial Agents and Chemotherapy·M Michéa-HamzehpourJ C Pechère
Nov 26, 1997·Antimicrobial Agents and Chemotherapy·T KöhlerJ C Pechere
Apr 1, 1997·Antimicrobial Agents and Chemotherapy·N BiancoK Poole

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.